This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cardiovascular Interventions, Other  • Cardiovascular System  • Statistics and Research Methods  • Randomized Controlled Trial  • Prognosis/ Outcomes  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Philippe Gabriel Steg, MD; José López-Sendón, MD; Esteban Lopez de Sa, MD; Shaun G. Goodman, MD; Joel M. Gore, MD; Frederick A. Anderson Jr, PhD; Dominique Himbert, MD; Jeanna Allegrone, MS; Frans Van de Werf, MD; for the GRACE Investigators

Arch Intern Med. 2007;167(1):68-73.

Background  Patients enrolled in randomized clinical trials (RCTs) may not reflect those seen in real-life practice. Our goal was to compare patients eligible for enrollment but not enrolled in contemporary RCTs of reperfusion therapy with patients who would have been ineligible and also with patients with acute myocardial infarction (AMI) participating in RCTs.

Methods  Consecutive patients with AMI (n = 8469) enrolled in the GRACE registry (Global Registry of Acute Coronary Events) were divided into 3 groups: RCT participants (11%; n = 953), eligible nonenrolled patients (55%; n = 4669), and ineligible patients (34%; n = 2847). Our main outcome measures were hospital mortality rates.

Results  Based on baseline characteristics or GRACE risk-score distribution, RCT participants had the lowest a priori risk of death; eligible patients had a higher risk; and ineligible patients had the highest risk. Actual hospital mortality showed a similar gradient (3.6%, 7.1%, and 11.4%, respectively) (P<.001). Multivariable analysis adjusting for baseline risk, use and type of reperfusion therapy, and delay from symptom onset to admission consistently showed a higher mortality rate for eligible nonenrolled patients than for RCT participants (odds ratio, 1.61; 95% confidence interval, 1.06-2.43; and odds ratio, 1.97; 95% confidence interval, 1.24-3.13, respectively).

Conclusions  Patients with AMI participating in RCTs have a lower baseline risk and experience lower mortality than nonenrolled patients, even when they are trial eligible. This difference is not entirely explained by differences in baseline risk, use and type of reperfusion therapy, and/or delays in presentation. Caution is necessary when extending the findings obtained in RCTs to the general population with AMI.

Author Affiliations: Department of Cardiology, Hôpital Bichat, Paris, France (Drs Steg and Himbert); Department of Cardiology, Hospital Universitario La Paz, Madrid, Spain (Drs López-Sendón and Lopez de Sa); Canadian Heart Research Centre and Division of Cardiology, St Michael's Hospital, University of Toronto, Toronto, Ontario (Dr Goodman); Department of Medicine (Dr Gore) and Center for Outcomes Research (Dr Anderson and Ms Allegrone), University of Massachusetts Medical School, Worcester; and Department of Cardiology, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium (Dr Van de Werf).
Group Information: A complete list of the GRACE Investigators can be found at http://www.outcomes-umassmed.org/grace.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Paramedic-led prehospital thrombolysis is safe and effective: the East Anglian experience
Khan et al.
Emerg. Med. J. 2009;26:452-455.
ABSTRACT | FULL TEXT  

Importance of Blood Pressure Control in Hypertensive Patients With Coronary Heart Disease in Clinical Practice to Reduce the Risk of Stroke
Barrios and Escobar
Stroke 2009;40:e469-e469.
FULL TEXT  

Predictors of infarct artery patency after prehospital thrombolysis: the multicentre, prospective, observational OPTIMAL study
Bongard et al.
Heart 2009;95:799-806.
ABSTRACT | FULL TEXT  

How to assess the external validity of therapeutic trials: a conceptual approach
Dekkers et al.
Int J Epidemiol 2009;0:dyp174v1-dyp174.
ABSTRACT | FULL TEXT  

Antihypertensive drugs in daily clinical practice: are there differences between genders?
Barrios et al.
Eur Heart J 2009;30:624-624.
FULL TEXT  

Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events
Steg et al.
Eur Heart J 2009;30:321-329.
ABSTRACT | FULL TEXT  

Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database
Gale et al.
Heart 2009;95:221-227.
ABSTRACT | FULL TEXT  

Reperfusion in Patients With Renal Dysfunction After Presentation With ST-Segment Elevation or Left Bundle Branch Block: GRACE (Global Registry of Acute Coronary Events)
Medi et al.
J Am Coll Cardiol Intv 2009;2:26-33.
ABSTRACT | FULL TEXT  

Sudden Death After Myocardial Infarction
Adabag et al.
JAMA 2008;300:2022-2029.
ABSTRACT | FULL TEXT  

Risk Factors Control in Diabetes: The "Real World" of Clinical Practice
Escobar and Barrios
The Diabetes Educator 2008;34:763-764.
FULL TEXT  

Death in Heart Failure: A Community Perspective
Henkel et al.
Circ Heart Fail 2008;1:91-97.
ABSTRACT | FULL TEXT  

Neighborhood Income and Individual Education: Effect on Survival After Myocardial Infarction
Gerber et al.
Mayo Clin Proc. 2008;83:663-669.
ABSTRACT | FULL TEXT  

Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events
Devlin et al.
Eur Heart J 2008;29:1275-1282.
ABSTRACT | FULL TEXT  

Acute heart failure in the emergency department: Short and long-term outcomes of elderly patients with heart failure
Ezekowitz et al.
Eur J Heart Fail 2008;10:308-314.
ABSTRACT | FULL TEXT  

"False-Positive" Cardiac Catheterization Laboratory Activation Among Patients With Suspected ST-Segment Elevation Myocardial Infarction
Larson et al.
JAMA 2007;298:2754-2760.
ABSTRACT | FULL TEXT  

Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?
Spencer et al.
Circulation 2007;116:2793-2801.
ABSTRACT | FULL TEXT  

The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2007;50:2254-2262.
FULL TEXT  

Propofol Associated with a Shorter Duration of Mechanical Ventilation than Scheduled Intermittent Lorazepam: A Database Analysis Using Project IMPACT
Fong et al.
The Annals of Pharmacotherapy 2007;41:1986-1991.
ABSTRACT | FULL TEXT  

Cardiovascular disease on a global scale: defining the path forward for research and practice
Mark et al.
Eur Heart J 2007;28:2678-2684.
ABSTRACT | FULL TEXT  

A Regional System to Provide Timely Access to Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
Henry et al.
Circulation 2007;116:721-728.
ABSTRACT | FULL TEXT  

Major bleeding after PCI. Where is our crystal ball?
Spencer and Steg
Eur Heart J 2007;28:1917-1919.
FULL TEXT